Erik Torell

675 total citations
16 papers, 503 citations indexed

About

Erik Torell is a scholar working on Infectious Diseases, Clinical Biochemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Erik Torell has authored 16 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Clinical Biochemistry and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Erik Torell's work include Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Streptococcal Infections and Treatments (5 papers). Erik Torell is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Streptococcal Infections and Treatments (5 papers). Erik Torell collaborates with scholars based in Sweden, Norway and Denmark. Erik Torell's co-authors include Otto Cars, Sigvard Mölstad, Håkan Hanberger, Eva Melander, Gunilla Skoog, Ann Söderström, Cecilia Stålsby Lundborg, Mats Erntell, Lars Burman and Birgitta Lytsy and has published in prestigious journals such as Journal of Clinical Microbiology, The Lancet Infectious Diseases and Environmental Microbiology.

In The Last Decade

Erik Torell

15 papers receiving 474 citations

Peers

Erik Torell
Erik Torell
Citations per year, relative to Erik Torell Erik Torell (= 1×) peers Guilherme Henrique Campos Furtado

Countries citing papers authored by Erik Torell

Since Specialization
Citations

This map shows the geographic impact of Erik Torell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Torell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Torell more than expected).

Fields of papers citing papers by Erik Torell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Torell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Torell. The network helps show where Erik Torell may publish in the future.

Co-authorship network of co-authors of Erik Torell

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Torell. A scholar is included among the top collaborators of Erik Torell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Torell. Erik Torell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Holm, Karin, et al.. (2018). PubMed. 115. 1 indexed citations
2.
Waldenström, J., Martti Färkkilâ, Gunnar Norkrans, et al.. (2015). Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience. Scandinavian Journal of Gastroenterology. 51(3). 337–343. 11 indexed citations
3.
Lytsy, Birgitta, Johan Lindbäck, Erik Torell, et al.. (2010). A case–control study of risk factors for urinary acquisition of Klebsiella pneumoniae producing CTX-M-15 in an outbreak situation in Sweden. Scandinavian Journal of Infectious Diseases. 42(6-7). 439–444. 7 indexed citations
5.
Mölstad, Sigvard, Mats Erntell, Håkan Hanberger, et al.. (2008). Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. The Lancet Infectious Diseases. 8(2). 125–132. 188 indexed citations
6.
Hambræus, Anna, et al.. (2006). [If good hand hygiene routines are not followed no private rooms in the world will help].. PubMed. 102(48). 3716–7. 1 indexed citations
7.
Lytsy, Birgitta, Otto Cars, & Erik Torell. (2006). [Quinolones--a cure which became a threat. Accelerating resistance development demands stricter indications].. PubMed. 102(48). 3651–6, 3659. 2 indexed citations
9.
Iversen, Aina, Inger Kühn, Mokhlasur Rahman, et al.. (2003). Evidence for transmission between humans and the environment of a nosocomial strain of Enterococcus faecium. Environmental Microbiology. 6(1). 55–59. 66 indexed citations
10.
Torell, Erik, et al.. (2003). Clonality among ampicillin-resistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance. Clinical Microbiology and Infection. 9(10). 1011–1019. 25 indexed citations
11.
Torell, Erik. (2003). Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1237 Epidemiology of Enterococci with Acquired Resistance to Antibiotics in Sweden Special emphasis on Ampicillin and Vancomycin. 2 indexed citations
12.
Torell, Erik. (2001). Ampicillin-resistant Enterococci in a Swedish University Hospital: Nosocomial Spread and Risk Factors for Infection. Scandinavian Journal of Infectious Diseases. 33(3). 182–187. 10 indexed citations
14.
Wesslén, Lars, et al.. (1999). [Three Swedish cases of African tick-bite fever. Can our native Rickettsia species cause disease in humans?].. PubMed. 96(37). 3888–90. 3 indexed citations
15.
Torell, Erik, et al.. (1997). Intrahospital Spread of Vancomycin-resistant Enterococcus faecium in Sweden. Scandinavian Journal of Infectious Diseases. 29(3). 259–263. 34 indexed citations
16.
Torell, Erik, et al.. (1996). [Poisonings with analgesics. Paracetamol and dextropropoxyphene dominate and cause the most severe symptoms in a 3-year material].. PubMed. 93(20). 1955–60. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026